calcium channel blockers also potentiate the antitumor activities of several dna-interacting drugs , such as adriamycin , thp-adriamycin , daunomycin , aclacinomycin a , mitomycin c , actinomycin d , mitoxantrone , and nogalamycin derivatives in p388 leukemia resistant to adriamycin .
C0011015
daunomycin
C0028261
nogalamycin